SPONSOR
Zhejiang University
Total Trials
12
Recruiting
12
Phases
Phase 3, Phase 1, Phase 2, Phase 2, EARLY_Phase 1
Conditions studied: Polymyalgia RheumaticaAdvanced Hepatocellular Carcinoma (HCC)Childhood ObesityAnemiaPregnancy ComplicationsPregnancy; HypertensionFeeding BehaviorLiver Transplant; ComplicationsMetastatic Pancreatic CarcinomaColorectal Cancer
Zhejiang University is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Polymyalgia Rheumatica, Advanced Hepatocellular Carcinoma (HCC), Childhood Obesity, Anemia.
The trial portfolio spans Phase 3, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhejiang University
How many clinical trials has Zhejiang University sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Zhejiang University, of which 12 are actively recruiting participants. These trials cover conditions including Polymyalgia Rheumatica, Advanced Hepatocellular Carcinoma (HCC), Childhood Obesity. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhejiang University research focus on?
Zhejiang University clinical trials span Polymyalgia Rheumatica, Advanced Hepatocellular Carcinoma (HCC), Childhood Obesity, Anemia, Pregnancy Complications, and additional conditions. The research pipeline includes Phase 3, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhejiang University clinical trial?
To participate in a Zhejiang University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhejiang University trials with current recruitment status updated daily.
Clinical Trials by Zhejiang University
NCT06172361 Phase 3
Recruiting
Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica
Polymyalgia Rheumatica
NCT07123545 Phase 1, Phase 2
Recruiting
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma (HCC)
NCT03217656
Recruiting
The Jiaxing Birth Cohort in China
Childhood Obesity
NCT06048445
Recruiting
Placement of Biliary Drainage Stent to Prevent Biliary Intestinal Anastomosis After Liver Transplantation in Children
Liver Transplant; Complications
NCT06770452 Phase 2
Recruiting
HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
Metastatic Pancreatic Carcinoma
NCT07581912 Phase 2
Recruiting
Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases
Colorectal Cancer
NCT05881616
Recruiting
Study on Serum Metabolomics of GDM
GDM
NCT04662294 EARLY_Phase 1
Recruiting
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Acute Myeloid Leukemia
NCT06076226
Recruiting
A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation
Acute Leukemia
NCT06793241 EARLY_Phase 1
Recruiting
Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia
NCT06937567 EARLY_Phase 1
Recruiting
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Biliary Tract Cancer
NCT06920433 EARLY_Phase 1
Recruiting
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology